Grace Therapeutics, Inc. (GRCE) Net margin 2022–2023
Grace Therapeutics, Inc. (GRCE) net profit margin by fiscal year — reported net income divided by reported revenue.
-42.4%FY2023 · since FY2022: -5009.7% → -42.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -42.4% | +4967.3 pp |
| FY2022 | -5009.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More GRCE financial trends
GRCE RevenueGRCE Net incomeGRCE Gross profitGRCE Gross marginGRCE Operating incomeGRCE Operating marginGRCE Operating cash flowGRCE Free cash flowGRCE Capital expendituresGRCE Return on equityGRCE Stock buybacksGRCE Dividends paidGRCE Total assetsGRCE Total liabilitiesGRCE Shareholders’ equityGRCE overview →